InMode (NASDAQ:INMD – Get Free Report) is expected to announce its Q3 2026 results before the market opens on Wednesday, November 11th. Analysts expect InMode to post earnings of $0.3220 per share and revenue of $91.58 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Wednesday, November 11, 2026 at 8:30 AM ET.
InMode Price Performance
INMD opened at $13.33 on Monday. The company has a 50 day moving average of $14.25 and a two-hundred day moving average of $14.32. InMode has a 52-week low of $12.72 and a 52-week high of $16.67. The company has a market cap of $766.21 million, a P/E ratio of 10.84 and a beta of 1.98.
Analysts Set New Price Targets
Separately, Weiss Ratings lowered InMode from a “sell (d+)” rating to a “sell (d)” rating in a research note on Monday, November 2nd. One analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $16.00.
Read Our Latest Report on INMD
About InMode
InMode Ltd. (NASDAQ: INMD) is a global medical technology company that develops and commercializes energy-based platforms for aesthetic and medical treatments. Its systems are designed to support minimally invasive and noninvasive procedures performed by physicians and other healthcare professionals.
The company’s product portfolio includes platforms and handpieces used in facial and body contouring, skin resurfacing, skin tightening, hair removal, and women’s health applications. Its technologies include radio-frequency and other energy-based treatments, with products such as Morpheus8, BodyTite, FaceTite, Optimas, and EmpowerRF serving a range of clinical and aesthetic needs.
Founded in 2008, InMode sells its products through direct sales and distribution channels to medical practices, clinics, and other healthcare providers.
Read More
- Five stocks we like better than InMode
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.
